Atricure Stock Performance
| ATRC Stock | USD 34.18 1.02 3.08% |
The firm shows a Beta (market volatility) of 1.29, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. At this point, AtriCure has a negative expected return of -0.12%. Please make sure to confirm AtriCure's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if AtriCure performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AtriCure has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 84.3 M | |
| Total Cashflows From Investing Activities | 30.2 M |
AtriCure Relative Risk vs. Return Landscape
If you would invest 3,766 in AtriCure on August 22, 2025 and sell it today you would lose (348.00) from holding AtriCure or give up 9.24% of portfolio value over 90 days. AtriCure is currently does not generate positive expected returns and assumes 2.4726% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than AtriCure, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AtriCure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AtriCure, and traders can use it to determine the average amount a AtriCure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0501
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATRC |
Estimated Market Risk
| 2.47 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AtriCure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AtriCure by adding AtriCure to a well-diversified portfolio.
AtriCure Fundamentals Growth
AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.
| Return On Equity | -0.0611 | ||||
| Return On Asset | -0.0265 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 1.57 B | ||||
| Shares Outstanding | 49.72 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 3.45 X | ||||
| Price To Sales | 3.18 X | ||||
| Revenue | 465.31 M | ||||
| EBITDA | (18.53 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 76.53 M | ||||
| Debt To Equity | 0.16 % | ||||
| Book Value Per Share | 9.59 X | ||||
| Cash Flow From Operations | 12.2 M | ||||
| Earnings Per Share | (0.61) X | ||||
| Total Asset | 609.33 M | ||||
| Retained Earnings | (401.75 M) | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
About AtriCure Performance
By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company was incorporated in 2000 and is headquartered in Mason, Ohio. Atricure operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 875 people.Things to note about AtriCure performance evaluation
Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AtriCure generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| Over 97.0% of the company shares are held by institutions such as insurance companies |
- Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
- Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |